+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emergent BioSolutions, Inc. - logo

Emergent BioSolutions manufactures immunobiotics such as vaccines and immune globulins that assist the body’s immune system. The company’s biodefense segment develops drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients exposed to anthrax and botulinum toxin. The company, which was founded in 1998, is based in Rockville, Maryland.

Anthrax (Infectious Disease) - Drugs in Development, 2021 - Product Thumbnail Image

Anthrax (Infectious Disease) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
From
Cholera (Infectious Disease) - Drugs in Development, 2021 - Product Thumbnail Image

Cholera (Infectious Disease) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Diphtheria Global Market Report 2024 - Product Thumbnail Image

Diphtheria Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
Dengue - Pipeline Insight, 2024 - Product Thumbnail Image

Dengue - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Influenza - Pipeline Insight, 2024 - Product Thumbnail Image

Influenza - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 280 Pages
  • Global
From
From
From
Anthrax - Pipeline Insight, 2024 - Product Thumbnail Image

Anthrax - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Chikungunya - Pipeline Insight, 2024 - Product Thumbnail Image

Chikungunya - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Marburg virus disease - Pipeline Insight, 2024 - Product Thumbnail Image

Marburg virus disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
Loading Indicator